文献速递妇科

降低风险的输卵管卵巢切除术对绝经后女性性类固醇激素血清水平的影响:一项NRG肿瘤学/妇科肿瘤组研究

Effect of risk-reducing salpingo-oophorectomy on sex steroid hormone serum levels among postmenopausal women: an NRG Oncology/Gynecologic Oncology Group study.
PubMed 文献 · Am J Obstet Gynecol · 2022-02-22

本研究纳入接受降低风险的输卵管卵巢切除术的绝经后女性180例和卵巢癌筛查对照38例,比较基线与随访的性类固醇激素水平。经阴道超声测量的卵巢体积与病理测量仅中度相关(Spearman ρ=0.42),且与激素水平无关。仅雌二醇在手术后显著下降(变化百分比-61.9 vs 对照+15.2,P=.02),其他激素无显著差异。

要点

  • 经阴道超声卵巢体积与病理测量仅中度相关(Spearman ρ=0.42)。
  • 雌二醇在降低风险的输卵管卵巢切除术后显著下降(变化百分比-61.9 vs 对照+15.2,P=.02)。
  • 其他性类固醇激素手术前后无显著差异,卵巢体积与激素水平不相关。

核心结论

  • 经阴道超声测量的卵巢体积与病理标本直接测量仅中度相关,且与绝经后女性性类固醇激素水平不相关。
  • 降低风险的输卵管卵巢切除术后仅雌二醇显著下降,其他激素无显著变化,对长期不良结局的影响尚不明确。

研究设计与样本

  • 国际前瞻性研究(妇科肿瘤组-0199)的二次分析,纳入绝经后接受降低风险的输卵管卵巢切除术者180例和卵巢癌筛查对照38例。
  • 对照按绝经年龄、入组年龄和采血间隔频数匹配,基线及随访检测9种激素,卵巢体积用经阴道超声和病理报告测量。

主要发现

  • 经阴道超声卵巢体积与病理报告测量中度相关(Spearman ρ=0.42)。
  • 病例手术至随访中位时间13.3个月(范围6.0-19.3),对照基线与随访中位时间12.7个月(范围8.7-13.4)。
  • 雌二醇变化百分比术后-61.9 vs 对照+15.2(P=.02),其余激素无显著差异。
  • 性类固醇水平随年龄下降,但与经阴道超声卵巢体积、体重指数或绝经时间不相关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Risk-reducing salpingo-oophorectomy is an effective ovarian cancer risk reduction strategy. However, bilateral oophorectomy has also been associated with increased long-term nonneoplastic sequelae, effects suggested to be mediated through reductions in systemic sex steroid hormone levels. Currently, it is unclear whether the postmenopausal ovary contributes to the systemic hormonal milieu or whether postmenopausal ovarian volume or other factors, such as body mass index and age, affect systemic hormone levels. OBJECTIVE: We examined the impact of oophorectomy on sex steroid hormone levels in postmenopausal women. Furthermore, we explored how well ovarian volume measured by transvaginal ultrasound correlated with direct ovarian measures obtained during surgical pathology evaluation and investigated the association between hormone levels and ovarian volumes. STUDY DESIGN: Postmenopausal women who underwent risk-reducing salpingo-oophorectomy (180 cases) or ovarian cancer screening (38 controls) enrolled in an international, prospective study of risk-reducing salpingo-oophorectomy and risk of ovarian cancer algorithm-based screening among women at increased risk of ovarian cancer (Gynecologic Oncology Group-0199) were included in this analysis. Controls were frequency matched to the cases on age at menopause, age at study entry, and time interval between blood draws. Ovarian volume was calculated using measurements obtained from transvaginal ultrasound in both cases and controls and measurements recorded in surgical pathology reports from cases. Serum hormone levels of testosterone, androstenedione, androstenediol, dihydrotestosterone, androsterone, dehydroepiandrosterone, estrone, estradiol, and sex hormone-binding globulin were measured at baseline and follow-up. Spearman correlation coefficients were used to compare ovarian volumes as measured on transvaginal ultrasound and pathology examinations. Correlations between ovarian volumes by transvaginal ultrasound and measured hormone levels were examined using linear regression models. All models were adjusted for age. Paired t tests were performed to evaluate individual differences in hormone levels before and after risk-reducing salpingo-oophorectomy. RESULTS: Ovarian volumes measured by transvaginal ultrasound were only moderately correlated with those reported on pathology reports (Spearman rho [ρ]=0.42). The median time interval between risk-reducing salpingo-oophorectomy and follow-up for the cases was 13.3 months (range, 6.0-19.3), and the median time interval between baseline and follow-up for the controls was 12.7 months (range, 8.7-13.4). Sex steroid levels decreased with age but were not correlated with transvaginal ultrasound ovarian volume, body mass index, or time since menopause. Estradiol levels were significantly lower after risk-reducing salpingo-oophorectomy (percentage change, -61.9 post-risk-reducing salpingo-oophorectomy vs +15.2 in controls; P=.02), but no significant differences were seen for the other hormones. CONCLUSION: Ovarian volumes measured by transvaginal ultrasound were moderately correlated with volumes directly measured on pathology specimens and were not correlated with sex steroid hormone levels in postmenopausal women. Estradiol was the only hormone that declined significantly after risk-reducing salpingo-oophorectomy. Thus, it remains unclear whether the limited post-risk-reducing salpingo-oophorectomy changes in sex steroid hormones among postmenopausal women impact long-term adverse outcomes.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Mai PL, Miller A, Black A, et al. Effect of risk-reducing salpingo-oophorectomy on sex steroid hormone serum levels among postmenopausal women: an NRG Oncology/Gynecologic Oncology Group study. Am J Obstet Gynecol. 2022. PMID: 35216968. doi:10.1016/j.ajog.2022.02.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。